Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 18, 2026
Why Is Weave Communications (WEAV) Stock Up +31.83% Today?

Why Is Weave Communications (WEAV) Stock Up +31.83% Today?

Key Takeaways

  • Shares of WEAV surged 31.83% to $7.29 in Tuesday morning trading after the company announced a $650 million all-cash acquisition.
  • The primary catalyst was a definitive agreement for Francisco Partners to acquire Weave for $7.40 per share in cash.
  • The offer represents a premium of roughly 34% to Monday's closing price of $5.53.
  • Secondary support came from B. Riley, which initiated coverage with a Buy rating and an $8.25 price objective.
  • The deal is expected to close in the fourth quarter of 2026, subject to shareholder and regulatory approvals; traders are watching the spread between the market price and the $7.40 offer.

Opening Summary

Weave Communications, Inc. (WEAV), a Lehi, Utah-based software company that provides an AI-powered patient communication, engagement, and payments platform for small and medium-sized healthcare practices, saw its shares rally Tuesday after the company agreed to be acquired by private equity firm Francisco Partners. The stock was trading at $7.29 as of 9:41 a.m. ET, up $1.76, or 31.83%, from Monday's close of $5.53. The move was decisively upward and was driven by the acquisition announcement.

Acquisition Announcement Drives the Rally

WEAV said it entered into a definitive agreement under which Francisco Partners will acquire the company for approximately $650 million. Shareholders will receive $7.40 per share in cash, a price that stands roughly 34% above Monday's closing level of $5.53. The board unanimously approved the transaction, which is expected to close in the fourth quarter of 2026. Once completed, WEAV will become a privately held company and its shares will be delisted from the New York Stock Exchange.

Management framed the deal as an opportunity to accelerate investment in Weave's AI platform and deepen its payments and revenue-cycle capabilities. The company said it will keep the Weave name and its Lehi headquarters. Because the buyout is an all-cash transaction, the $7.40 per-share consideration effectively anchored Tuesday's trading, with shares holding just below the offer price to reflect closing risk, regulatory review, and the time remaining until the expected completion.

Analyst Initiation Adds Secondary Support

In a separate Tuesday note, B. Riley initiated coverage of WEAV with a Buy rating and an $8.25 price target. While the target sits above the announced acquisition price, the initiation added another favorable signal on a day when the takeover announcement dominated trading. The company-specific nature of the M&A news meant the analyst note played a clear but secondary role in the price action.

Market Context and Trading Activity

Trading activity was heavy following the announcement. The stock gapped toward the deal price and moved well above its 50-day moving average of $6.16 and its 200-day moving average of $5.66. Early-session volume was elevated relative to normal trading, consistent with event-driven and merger-arbitrage flows. The rally was company-specific rather than a reflection of broad-market movement.

The buyout announcement also arrives after a volatile stretch for WEAV. Earlier in August, shares fell after the company reported second-quarter results, even as Weave reached an operating-income milestone, because it trimmed full-year revenue guidance to a range of $273 million to $275 million amid a go-to-market transition. The $7.40 offer reframes that operating reset by giving shareholders a cash exit well above the stock's post-earnings trough.

What Comes Next for WEAV

The Francisco Partners transaction is expected to close in the fourth quarter of 2026, subject to approval by Weave shareholders, receipt of regulatory clearances, and other customary closing conditions. Until those conditions are satisfied, shares of WEAV are likely to remain closely tied to the $7.40 offer price, with day-to-day moves determined by the perceived probability and timing of completion.

Key risks include the possibility that the transaction does not close, that regulatory review takes longer than expected, or that a competing proposal emerges. Weave's next quarterly report could provide an operating update, but the pending acquisition is expected to remain the dominant focus for traders until the deal is resolved.

Trending AI Robots

Tickeron's Trending AI Robots page features AI-powered trading bots currently showing the strongest performance under prevailing market conditions. Tickeron offers hundreds of bots covering thousands of tickers, with each bot varying by strategy, timeframe, performance metrics, and traded symbols. Traders looking to complement their own analysis of event-driven moves can explore the curated selection for additional AI-driven signals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WEAV

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Aroon Indicator for WEAV shows an upward move is likely

WEAV's Aroon Indicator triggered a bullish signal on September 09, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 223 similar instances where the Aroon Indicator showed a similar pattern. In of the 223 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where WEAV's RSI Indicator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 18, 2026. You may want to consider a long position or call options on WEAV as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WEAV just turned positive on August 18, 2026. Looking at past instances where WEAV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

WEAV moved above its 50-day moving average on August 18, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for WEAV crossed bullishly above the 50-day moving average on August 25, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WEAV advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

WEAV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where WEAV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WEAV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WEAV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.873) is normal, around the industry mean (7.166). WEAV has a moderately low P/E Ratio (0.000) as compared to the industry average of (44.602). WEAV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.474). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (2.221) is also within normal values, averaging (5.936).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WEAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.76B. The market cap for tickers in the group ranges from 708 to 42.25B. VEEV holds the highest valuation in this group at 42.25B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -4%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 18%. ONMD experienced the highest price growth at 13%, while WAY experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -25%. For the same stocks of the Industry, the average monthly volume growth was -43% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 75
Price Growth Rating: 53
SMR Rating: 86
Profit Risk Rating: 98
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
WEAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Details
Industry
N/A
Address
1331 West Powell Way
Phone
+1 385 331-4164
Employees
904
Web
https://www.getweave.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.